ArticleJournal of clinical medicine2021

Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure.

Luis M Pérez-Belmonte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.